By Dr Jonathan Brett

Journal articles

Brett J; Maust DT; Bouck Z; Ignacio RV; Mecredy G; Kerr EA; Bhatia S; Elshaug AG; Pearson SA, 2018, 'Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016', Journal of the American Geriatrics Society, 66, pp. 1180 - 1185, http://dx.doi.org/10.1111/jgs.15292

Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA, 2018, 'Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics', Pharmacoepidemiology and Drug Safety, 27, pp. 504 - 512, http://dx.doi.org/10.1002/pds.4369

Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA, 2018, 'The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 27, pp. 439 - 446, http://dx.doi.org/10.1002/pds.4408

Chalmers K; Badgery-Parker T; Pearson SA; Brett J; Scott IA; Elshaug AG, 2018, 'Developing indicators for measuring low-value care: Mapping Choosing Wisely recommendations to hospital data', BMC Research Notes, 11, http://dx.doi.org/10.1186/s13104-018-3270-4

Badgery-Parker T; Pearson SA; Chalmers K; Brett J; Scott IA; Dunn S; Onley N; Elshaug AG, 2018, 'Low-value care in Australian public hospitals: Prevalence and trends over time', BMJ Quality and Safety, 28, pp. 205 - 214, http://dx.doi.org/10.1136/bmjqs-2018-008338

Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA, 2017, 'Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study', British Journal of Clinical Pharmacology, 83, pp. 2581 - 2588, http://dx.doi.org/10.1111/bcp.13369

Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA, 2017, 'Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure', Australian and New Zealand Journal of Psychiatry, 51, pp. 990 - 999, http://dx.doi.org/10.1177/0004867417721018

Brett J; Dawson A; Ivers R; Lawrence L; Barclay S; Conigrave K, 2017, 'Healing at home: Developing a model for ambulatory alcohol "detox" in an Aboriginal community controlled health service', International Journal of Indigenous Health, 12, pp. 24 - 38, http://dx.doi.org/10.18357/ijih121201716906

Brett J; Elshaug AG; Bhatia RS; Chalmers K; Badgery-Parker T; Pearson SA, 2017, 'A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: An Australian case study', Implementation Science, 12, pp. 58, http://dx.doi.org/10.1186/s13012-017-0585-9

McNamara K, 2016, 'Benzodiazepines', AUSTRALIAN PRESCRIBER, 39, pp. 33 - 33, http://dx.doi.org/10.18773/austprescr.2016.016

Brett J, 2015, 'Comments: Letters to the editor: Concerns about quetiapine', Australian Prescriber, 38, pp. 189 - 190

Brett J, 2015, 'Concerns about quetiapine', AUSTRALIAN PRESCRIBER, 38, pp. 189 - +, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365802100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brett J; Murnion B, 2015, 'Management of benzodiazepine misuse and dependence', Australian Prescriber, 38, pp. 152 - 155, http://dx.doi.org/10.18773/austprescr.2015.055

Brett J; Murnion B, 2015, 'Pregabalin to treat ciguatera fish poisoning', Clinical Toxicology, 53, pp. 588, http://dx.doi.org/10.3109/15563650.2015.1052499

Brett J, 2015, 'Concerns about quetiapine', Australian Prescriber, 38, pp. 95 - 97, http://dx.doi.org/10.18773/austprescr.2015.032

Montebello ME; Brett B, 2015, 'Misuse and associated harms of quetiapine and other atypical antipsychotics', Current Topics in Behavioral Neurosciences, pp. 1 - 15, http://dx.doi.org/10.1007/7854_2015_424

Brett J; Dawson AH; Brown JA, 2014, 'Clenbuterol toxicity: A NSW Poisons Information Centre experience', Medical Journal of Australia, 200, pp. 219 - 221, http://dx.doi.org/10.5694/mja13.10982

Baysari M; Brett J; Lam V; Milder T; Killen L; Chau AMT; McMullan B; Harkness J; Marriot D; Day R, 2013, 'Pneumonia Severity Scores and Prescribing Antibiotics for Community-Acquired Pneumonia at an Australian Hospital', Journal of Pharmacy Practice and Research, 43, pp. 97 - 101

Brett J; Chong O; Graham GG; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69

Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067

Brett J, 2012, 'Why have prison needle exchange programmes not yet been rolled out in the UK?', BMJ (Online), 345, http://dx.doi.org/10.1136/bmj.e6211

Baysari MT; Tang T; Brett J; Day RO, 2012, 'Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'', Journal of Pharmacy Practice and Research, 42, pp. 178 - 179

Lipworth WL; Kerridge IH; Brett J; Day RO, 2011, 'How clinical and resaerch failures lead to suboptimal prescribing: the example of chronic gout', British Medical Journal, 343, pp. 1 - 3

Lipworth WL; Kerridge I; Brett J; Day R, 2011, 'How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.', British Medical Journal, 343, pp. d7459, http://dx.doi.org/10.1136/bmj.d7459

Day R, 2000, 'In Reply', The Australian Journal of Hospital Pharmacy, 30, pp. 120 - 120, http://dx.doi.org/10.1002/jppr2000303120a

Back to profile page